KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Edwards Lifesciences (EW) Non-Current Receivables (2016)

Edwards Lifesciences (EW) has 6 years of Non-Current Receivables data on record, last reported at $5.3 million in Q3 2016.

  • For Q3 2016, Non-Current Receivables fell 3.64% year-over-year to $5.3 million; the TTM value through Sep 2016 reached $5.3 million, down 3.64%, while the annual FY2015 figure was $3.6 million, 37.93% down from the prior year.
  • Non-Current Receivables reached $5.3 million in Q3 2016 per EW's latest filing, roughly flat from $5.3 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $21.4 million in Q1 2012 and bottomed at $3.6 million in Q4 2015.
  • Average Non-Current Receivables over 5 years is $8.4 million, with a median of $7.3 million recorded in 2013.
  • Peak YoY movement for Non-Current Receivables: plummeted 59.76% in 2012, then increased 19.27% in 2013.
  • A 5-year view of Non-Current Receivables shows it stood at $9.9 million in 2012, then dropped by 26.26% to $7.3 million in 2013, then dropped by 20.55% to $5.8 million in 2014, then tumbled by 37.93% to $3.6 million in 2015, then soared by 47.22% to $5.3 million in 2016.
  • Per Business Quant database, its latest 3 readings for Non-Current Receivables were $5.3 million in Q3 2016, $5.3 million in Q2 2016, and $5.8 million in Q1 2016.